COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE(CHMP)
GUIDELINE ON THE INVESTIGATION OF BIOEQUIVALENCE
DRAFT
http://www.emea.europa.eu/pdfs/human/qwp/140198enrev1.pdf
Regulatory information links on new drug development ; study designing, planning and statistics
0 件のコメント:
コメントを投稿